Form 4: Peraso CFO Granted 25,000 Stock Options
Insider Transaction Report
Peraso Inc.'s Chief Financial Officer, James Sullivan, was granted 25,000 stock options with a strike price of $0.8399, vesting monthly over three years.
Summary
- James Sullivan, Chief Financial Officer of Peraso Inc., was granted 25,000 stock options.
- The options have an exercise price of $0.8399 per share.
- The grant date for these options was August 7, 2025.
- The options will vest at a rate of 1/36th of the total shares monthly, starting from August 7, 2025, over a period of three years.
- The expiration date for these options is August 7, 2035.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. The grant of stock options is a routine compensation event that aligns executive incentives with shareholder value, which is generally viewed positively. However, it does not indicate any immediate operational or financial performance changes.
Positives
- Granting of stock options to the Chief Financial Officer aligns management's incentives with shareholder interests, encouraging long-term performance.
- The options have a 10-year expiration period, providing a long-term incentive horizon.
Risks
- The value of the stock options is dependent on the future performance of Peraso Inc.'s stock price. If the stock price does not exceed the exercise price of $0.8399, the options may expire worthless.
- Potential for future dilution to existing shareholders if the options are exercised, increasing the number of outstanding shares.
Future Outlook
The stock option grant is designed to incentivize the Chief Financial Officer over a three-year vesting period, aligning future performance with long-term shareholder value.
Industry Context
The granting of stock options to key executives like the CFO is a common practice in the technology and semiconductor industries, particularly for growth-oriented companies like Peraso Inc., to attract, retain, and motivate talent by linking compensation to company performance and shareholder returns.
Comparison to Industry Standards
- Granting stock options with a multi-year vesting schedule (3 years) is a standard practice for executive compensation in the technology sector, comparable to practices at companies like Broadcom (AVGO) or Qualcomm (QCOM) for aligning long-term executive incentives.
- The exercise price being at or near the market price on the grant date (implied by $0.00 price of derivative security) is typical for incentive stock options.
Related Party Transactions
- James Sullivan, Chief Financial Officer, was granted 25,000 stock options by Peraso Inc. as part of his compensation.
Stakeholder Impact
- Shareholders: Potential for future dilution if options are exercised, but also potential for increased long-term value if executive incentives lead to improved company performance.
- Management: The CFO is incentivized to improve company performance to increase the value of the options.
Next Steps
- The stock options will vest monthly over the next 36 months, starting August 7, 2025.
Key Dates
| Date | Description |
|---|---|
| 08/07/2025 | Date of earliest transaction (grant date of stock options) and date options become exercisable and start vesting. |
| 08/11/2025 | Date of filing and signature by James Sullivan. |
| 08/07/2035 | Expiration date of stock options. |
Recommendation
holdThe filing is a routine Form 4 reporting an executive stock option grant, which is a standard compensation practice. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The grant aligns executive incentives with long-term shareholder value, which is a neutral to slightly positive factor, but not a catalyst for a 'buy' or 'sell' decision on its own.
Keywords
Peraso Inc., PRSO, Stock Options, CFO, Executive Compensation, SEC Form 4, Insider Transaction, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.